|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/68 | |
| C07K 16/28 | |||
| A61K 47/50 | |||
| A61P 35/00 |
| (11) | Number of the document | 3016980 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14819422.8 |
| Date of filing the European patent application | 2014-07-04 | |
| (97) | Date of publication of the European application | 2016-05-11 |
| (45) | Date of publication and mention of the grant of the patent | 2020-05-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CA2014/000543 |
| Date | 2014-07-04 |
| (87) | Number | WO 2015/000062 |
| Date | 2015-01-08 |
| (30) | Number | Date | Country code |
| 201361843113 P | 2013-07-05 | US | |
| 201461944157 P | 2014-02-25 | US |
| (72) |
TIKHOMIROV, Ilia Alexandre, CA
|
| (73) |
Formation Biologics Inc.,
750 Boul. Saint-Laurent, Suite 101, Montréal, Québec H2Y 2Z4,
CA
|
| (54) | EGFR ANTIBODY CONJUGATES |
| EGFR ANTIBODY CONJUGATES |